secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRESCENT BIOPHARMA, INC. (CBIO)
CIK:        0001253689
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001558370-24-009508
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

GlycoMimetics receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on June 21, 2024 for bid price below $1.00 for 30 consecutive business days.
- Has until December 18, 2024 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may transfer to Nasdaq Capital Market for an additional 180-day compliance period.
- Failure to regain compliance could result in delisting of GLYC common stock from Nasdaq.
- Company intends to monitor bid price and consider options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1253689/000155837024009508/0001558370-24-009508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1253689/000155837024009508/glyc-20240621x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer